Tech Center 1600 • Art Units: 1648 1671
This examiner grants 60% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17622044 | ADENO-ASSOCIATED VIRUS PURIFICATION METHODS | Non-Final OA | TAKEDA PHARMACEUTICAL COMPANY LIMITED |
| 18151174 | NIPAH VIRUS ENVELOPE PSEUDOTYPED LENTIVIRUSES AND METHODS OF THEIR USE | Non-Final OA | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 18022056 | ADENO-ASSOCIATED VIRUS COMPOSITIONS HAVING PREFERRED EXPRESSION LEVELS | Non-Final OA | California Institute of Technology |
| 17919997 | COMPOSITIONS AND METHODS FOR FORMATION AND SECRETION OF EXTRACELLULAR VESICLES AND AAV PARTICLES | Non-Final OA | DUKE UNIVERSITY |
| 18087173 | VIRUS SEPARATION | Final Rejection | Cytiva US LLC |
| 18817094 | Rhinovirus Vaccine | Non-Final OA | IP2IPO INNOVATIONS LIMITED |
| 17791981 | SYSTEM AND METHOD FOR PROCESSING VIRUS PREPARATIONS TO REDUCE HETEROGENEITY | Non-Final OA | THE TRUSTEES OF INDIANA UNIVERSITY |
| 17911367 | KIR 7.1 GENE THERAPY VECTORS AND METHODS OF USING THE SAME | Non-Final OA | Wisconsin Alumni Research Foundation |
| 18345478 | ANTI-SARS-COV-2 ANTIGEN BINDING POLYPEPTIDES, POLYPEPTIDE COMPLEXES AND METHODS OF USE THEREOF | Non-Final OA | The United States of America, As Represented by the Secretary, Dept. of Health and Human Services |
| 17767532 | PRODUCTION METHOD AND DETECTION METHOD OF AFRICAN SWINE FEVER VIRUS | Final Rejection | National Agriculture and Food Research Organization |
| 17919065 | ADENOVIRUS IMMUNOASSAY METHOD AND IMMUNOASSAY INSTRUMENT | Final Rejection | Denka Company Limited |
| 17615961 | MDBK IRF3/IRF7 KNOCK OUT MUTANT CELL AND ITS USE FOR VACCINE PRODUCTION | Non-Final OA | Intervet Inc. |
| 17263490 | ENGINERRED ANTIBODIES TO HIV ENV | Non-Final OA | The Scripps Research Institute |
| 17948868 | DUAL BIFUNCTIONAL VECTORS FOR AAV PRODUCTION | Final Rejection | uniQure biopharma B.V. |
| 18000638 | CHIMERIC ADENOVIRAL VECTORS | Non-Final OA | Vaxart, Inc. |
| 17416810 | NOROVIRUS VACCINE FORMULATIONS AND METHODS | Non-Final OA | TAKEDA VACCINES, INC. |
| 17274016 | DENGUE VACCINE UNIT DOSE AND ADMINISTRATION THEREOF | Final Rejection | Takeda Vaccines, Inc. |
| 17777112 | VIRAL INACTIVATION METHOD, METHOD FOR PRODUCING DRIED AMNION, AND DRIED AMNION | Final Rejection | SAKURA SEIKI CO., LTD. |
| 17633063 | CELLULAR COMPOSITIONS COMPRISING VIRAL VECTORS AND METHODS OF TREATMENT | Final Rejection | Mesoblast International Sárl |
| 18007441 | BACTERIOPHAGE, BACTERIAL WILT DISEASE CONTROL AGENT, AND BACTERIAL WILT DISEASE CONTROL METHOD | Non-Final OA | PANEFRI INDUSTRIAL CO., LTD. |
| 18007823 | ENHANCED PURIFICATION OF ADENO-ASSOCIATED VIRUS TO MORE EFFECTIVELY REMOVE CONTAMINATING DNA | Non-Final OA | Sartorius BIA Separations d.o.o. |
| 18011742 | METHOD FOR PREPARING ADENOVIRUS VECTOR VACCINE BY MEANS OF PERFUSION CULTURE PROCESS | Non-Final OA | CANSINO BIOLOGICS INC. |
| 18058403 | ANTIGENIC DETERMINANTS PROTECTIVE IMMUNITY, SERODIAGNOSTIC AND MULTIVALENT SUBUNITS PRECISION VACCINE AGAINST SARS-CoV-2 | Non-Final OA | ARABIAN GULF UNIVERSITY |
| 17736181 | ENGINEERED BACTERIOPHAGE T4 NANOPARTICLES AS A POTENTIAL TARGETED ACTIVATOR OF HIV-1 LATENCY IN CD4+ HUMAN T-CELLS | Final Rejection | The Catholic University of America |
| 17767195 | siRNA EXPRESSION VECTOR | Final Rejection | TAKARA BIO INC. |
| 17627162 | USE OF ION CONCENTRATIONS TO INCREASE THE PACKAGING EFFICIENCY OF RECOMBINANT ADENO-ASSOCIATED VIRUS | Final Rejection | CHARLES RIVER LABORATORIES, INC. |
| 17605524 | New Adeno-Associated Virus (AAV) Variants and Uses Thereof for Gene Therapy | Final Rejection | Universite Paris XIII Paris-Nord Villetaneuse |
| 17180351 | Composition and Methods for Treating Infectious Agents Using Pathogen-specific Antibodies | Non-Final OA | Anubis Bio Corporation |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy